Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Gasser R, Pätzold S, Holzwart E, Ablasser K, Kraigher-Krainer E, Friehs I, Lewinski D, Pieske B, Mächler H, Trantiner-Yates A, Tscheliessnig KH, Mangge H, Porta S, Gasser S
Immunological Implications in Experimental Myocardial Ischaemia: MPO (Myeloperoxidase) Expression Is Differentially Regulated by Beta-Blockers, While CD80 Expression Remains Unaffected
Journal of Clinical and Basic Cardiology 2011; 14 (1-4): 16-22

PDF    Summary    Overview   

Fig. 1: MPO Experiments This Image - Fig. 2: Interleukin Pathway Fig. 3: CD80 Experiments
Figure/Graphic 2: Interleukin Pathway
Interleukin pathway up-regulated by nebivolol, not by atenolol, during experimental ischaemia.
 
Interleukin Pathway
Previous Image Next Image   


Figure/Graphic 2: Interleukin Pathway
Interleukin pathway up-regulated by nebivolol, not by atenolol, during experimental ischaemia.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung